|
|
M Pontoglio, S Sreenan, M Roe, W Pugh, D Ostrega, A Doyen, A J Pick, A Baldwin, G Velho, P Froguel, M Levisetti, S Bonner-Weir, G I Bell, M Yaniv, K S Polonsky
J Clin Invest. 1998;
101(10):2215
doi:10.1172/JCI2548
Abstract |
Full text
| PDF

M
utations in the gene for the transcription factor hepatocyte nuclear factor (HNF) 1alpha cause maturity-onset diabetes of the young (MODY) 3, a form of diabetes that results from defects in insulin secretion. Since the nature of these defects has not been defined, we compared insulin secretory function in heterozygous [HNF-1alpha (+/-)] or homozygous [HNF-1alpha (-/-)] mice with null mutations in the HNF-1alpha gene with their wild-type littermates [HNF-1alpha (+/+)]. Blood glucose concentrations were similar in HNF-1alpha (+/+) and (+/-) mice (7.8+/-0.2 and 7.9+/-0.3 mM), but were significantly higher in the HNF-1alpha (-/-) mice (13.1+/-0.7 mM, P < 0.001). Insulin secretory responses to glucose and arginine in the perfused pancreas and perifused islets from HNF-1alpha (-/-) mice were < 15% of the values in the other two groups and were associated with similar reductions in intracellular Ca2+ responses. These defects were not due to a decrease in glucokinase or insulin gene transcription. beta cell mass adjusted for body weight was not reduced in the (-/-) animals, although pancreatic insulin content adjusted for pancreas weight was slightly lower (0.06+/-0.01 vs. 0.10+/-0.01 microg/mg, P < 0.01) than in the (+/+) animals. In summary, a null mutation in the HNF-1alpha gene in homozygous mice leads to diabetes due to alterations in the pathways that regulate beta cell responses to secretagogues including glucose and arginine. These results provide further evidence in support of a key role for HNF-1alpha in the maintenance of normal beta cell function.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(47)
| Title and authors |
Publication |
Year |
Effect of kidney disease on glucose handling (including genetic defects)
Joaquim Calado, René Santer, José Rueff
|
Kidney Int
|
2011 |
Use of mouse models in studying type 2 diabetes mellitus
Angela W.S. Lee, Roger D. Cox
|
Expert Rev. Mol. Med.
|
2011 |
Rapamycin protects against dominant negative-HNF1A-induced apoptosis in INS-1 cells
Angela M. Farrelly, Seán M. Kilbride, Caroline Bonner, Jochen H. M. Prehn, Maria M. Byrne
|
Apoptosis
|
2011 |
Recombinant adenovirus carrying the hepatocyte nuclear factor-1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice
Xin Zeng, Yong Lin, Chuan Yin, Xin Zhang, Bei-Fang Ning, Qing Zhang, Jun-Ping Zhang, Lei Qiu, Xiao-Ran Qin, Yue-Xiang Chen
|
Hepatology
|
2010 |
Growth factor control of pancreatic islet regeneration and function
Anke Assmann, Charlotte Hinault, Rohit N Kulkarni
|
Pediatric Diabetes
|
2009 |
Role of HNF-1α in regulating the expression of genes involved in cellular growth and proliferation in pancreatic beta-cells
Yuji Uchizono, Aaron C. Baldwin, Hiroya Sakuma, William Pugh, Kenneth S. Polonsky, Manami Hara
|
Diabetes Research and Clinical Practice
|
2009 |
Dominant-negative mutant hepatocyte nuclear factor 1α induces diabetes in transgenic-cloned pigs
Kazuhiro Umeyama, Masahito Watanabe, Hitoshi Saito, Mayuko Kurome, Sadaaki Tohi, Hitomi Matsunari, Keizaburo Miki, Hiroshi Nagashima
|
Transgenic Res
|
2009 |
The nuclear receptor coactivator AIB3 is a modulator of HOMA β-cell function in nondiabetic children
Hans Burghardt, Abel López-Bermejo, Bernhard Baumgartner, Lourdes Ibáñez, Joan Vendrell, Wifredo Ricart, Manuel Palacín, José Manuel Fernández-Real, Antonio Zorzano
|
Clinical Endocrinology
|
2008 |
Mechanisms of Disease: using genetically altered mice to study concepts of type 2 diabetes
Derek LeRoith, Domenico Accili
|
Nat Clin Pract Endocrinol Metab
|
2008 |
Role of HNF-1α and HNF-1β on insulin, IGF-1 and other potential target genes
Sachiko Kitanaka
|
Expert Rev Endocrinol Metab
|
2008 |
|